The EU Doesn’t Treat All <br />COVID-19 Vaccines Equally , When It Comes to Travelers.<br />Millions of people who have been vaccinated through COVAX, a worldwide initiative to grant equal access to COVID-19 vaccines.<br />could still find themselves <br />barred from entering the EU and other countries.<br />This is due to the fact that although the AstraZeneca vaccine manufactured in Europe has been given the green light.<br />the same vaccine produced in India has not.<br />EU regulators claim AstraZeneca hasn't completed the required paperwork detailing production practices and quality control standards for its Indian factory. .<br />But the factory has been inspected and approved by the World Health Organization (WHO).<br />The EU's reluctance to recognize the Indian-made version of the vaccine has the potential to complicate travel and confuse recipients concerning the efficacy of the shot.<br />According to the WHO, countries that decline vaccines it has authorized ...<br />... are "undermining confidence in lifesaving vaccines that have already been shown to be safe and effective, affecting uptake of vaccines and potentially putting billions of people at risk.".<br />... are "undermining confidence in lifesaving vaccines that have already been shown to be safe and effective, affecting uptake of vaccines and potentially putting billions of people at risk.".<br />... are "undermining confidence in lifesaving vaccines that have already been shown to be safe and effective, affecting uptake of vaccines and potentially putting billions of people at risk.".<br />According to the Associated Press, AstraZeneca did recently submit the paperwork for the Indian factory but didn't say why it had waited until now
